BFRI
Biofrontera Inc
NASDAQ: BFRI · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$1.08
-1.82% today
Updated 2026-04-30
Market cap
$12.58M
P/E ratio
—
P/S ratio
0.30x
EPS (TTM)
$-1.04
Dividend yield
—
52W range
$1 – $1
Volume
0.1M
Biofrontera Inc (BFRI) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-37.68M | $-12.37M | $-26.71M | $-16.20M | $-24.89M | $-10.27M | $-13.36M |
| Capital expenditures | $538000.00 | $11000.00 | $11000.00 | $38000.00 | $5000.00 | $60000.00 | $2000.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | — | $0.00 | $129000.00 | $1.85M | $1.04M | $1.02M | $951000.00 |
| Free cash flow | $-38.22M | $-12.38M | $-26.73M | $-16.24M | $-24.90M | $-10.33M | $-13.36M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — |